Deficiency of plasma platelet-activating factor (PAF) acetylhydrolase is an autosomal recessive syndrome that has been associated with severe asthma in Japanese children. Acquired deficiency has been described in several human diseases usually associated with severe inflammation. PAF acetylhydrolase catalyzes the degradation of PAF and related phospholipids, which have proinflammatory, allergic, and prothrombotic properties. Thus, a deficiency in the degradation of these lipids should increase the susceptibility to inflammatory and allergic disorders. Miwa et al. reported that PAF acetylhydrolase activity is absent in 4% of the Japanese population, which suggests that it could be a common factor in such disorders, but the molecular basis of the defect is unknown. We show that inherited deficiency of PAF acetylhydrolase is the result of a point mutation in exon 9 and that this mutation completely abolishes enzymatic activity. This mutation is the cause of the lack of enzymatic activity as expression in E. coli of a construct harboring the mutation results in an inactive protein. This mutation as a heterozygous trait is present in 27% in the Japanese population. This finding will allow rapid identification of subjects predisposed to severe asthma and other PAF-mediated disorders.
Introduction
Platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn -glycero-3-phosphocholine) 1 is a biologically active phospholipid with diverse potent biological effects (1) (2) (3) . PAF has been implicated as a mediator of physiological processes such as signaling and activation of proinflammatory cells, alteration of vascular permeability, and stimulation of glycogen metabolism, among many others (for review see reference 3). In addition to its role as a physiological mediator, PAF is associated with the pathology of several human diseases, particularly allergy and inflammation, affecting the respiratory, vascular, digestive and reproductive systems (4) . PAF exerts its actions at concentrations as low as 10 Ϫ 12 M (1). Its accumulation is tightly regulated at the synthetic and degradative levels to avoid the inappropriately high accumulation of PAF observed in many diseases.
PAF is degraded to inactive products by hydrolysis of the acetyl group at the sn -2 position, to produce the biologically inactive products lyso-PAF and acetate. This reaction is catalyzed by PAF acetylhydrolase, a calcium-independent phospholipase A 2 specific for hydrolysis of phospholipids containing short and/or oxidized chains at the sn -2 position of the glycerol backbone (5-11). Intracellular and plasma PAF acetylhydrolase activities have been described, purified and characterized biochemically (12) (13) (14) (15) . We recently isolated a cDNA encoding the human plasma PAF acetylhydrolase and showed that the recombinant enzyme abolishes PAF's pathological actions (16) . The predicted amino acid sequence of the plasma form of PAF acetylhydrolase contains a Gly-Xaa-SerXaa-Gly motif characteristic of lipases and esterases (16) . The serine residue in this conserved motif is essential for activity and it explains the ability of serine esterase inhibitors to abolish enzymatic activity (16, 17) . Finally, Inoue and co-workers have purified and cloned cDNAs encoding several intracellular PAF acetylhydrolases from bovine brain (18) (19) (20) .
The levels of PAF acetylhydrolase have been determined in blood from normal human subjects and individuals with a variety of pathological conditions (3, 4) . Alterations in PAF acetylhydrolase activity have been reported in several disease states and can potentially contribute to the pathogenesis of these conditions (3) . For example, acquired deficiency of PAF acetylhydrolase activity has been reported in patients with systemic lupus erythematosus and asthma (21, 22) , and increased levels of PAF have been reported in children with acute asthmatic attacks (23) . In addition to these acquired deficiencies, Miwa et al. described an inherited form of PAF acetylhydrolase deficiency (24) . This trait is inherited in an autosomal recessive fashion and has been observed only in the Japanese population (24) . Interestingly, the prevalence of this trait is higher in children with severe asthma, suggesting that the decreased ability to degrade PAF allows the phospholipid to accumulate and provoke or amplify the asthmatic response.
To determine the molecular basis of inherited PAF acetylhydrolase deficiency, we amplified all coding exons in the PAF acetylhydrolase gene using DNA isolated from subjects with normal and deficient levels of PAF acetylhydrolase activity. We report the identification of a point mutation near the ac-tive site of PAF acetylhydrolase that is present in Japanese subjects with undetectable levels of plasma activity.
Methods
DNA isolation and exon amplification. Blood was drawn from adult subjects by venipuncture and was anticoagulated with citrate. Epstein-Barr virus-transformed cell lines were established for each subject tested (25) . Cells for isolation of total genomic DNA were cultured in RPMI 1640 medium (Cellgrow, Mediatech, Washington, DC) supplemented with 15% fetal calf serum (Hyclone, Logan, UT). Genomic DNA was isolated by conventional techniques (26) and exon 9 was amplified by the polymerase chain reaction using these genomic DNA samples as templates (27) . Typically, the reactions (50 l) contained genomic DNA (100 ng), 50 pmol of each oligonucleotide primer, 200 M each of dCTP, dTTP, dGTP, and dATP, 1. The PCR products were purified and subcloned after digestion with the appropriate restriction enzymes into pBluescript II SK( ϩ ) (Stratagene, La Jolla, CA) or by blunt end ligation, as described (28) .
Human chromosome mapping. DNA from 25 well-characterized human/rodent somatic cell hybrids was purchased from Coriell Cell Repositories (Camden, NJ). PCR was performed using 100 ng of DNA from each hybrid cell line, in a total volume of 40 l. PCR of human, hamster, and mouse control DNAs revealed the presence of a 900-bp product only in the human DNA amplification. The primers used were as follows:
Sense primer I: 5 Ј -GACCTGGCATCTCATGG-3 Ј Antisense primer I: 5 Ј -ACCTCTCCTTTCACTGC-3 Ј Amplifications were performed as follows: first, one cycle at 94 Њ C for 5 min; second, 5 cycles at 94 Њ C (60 s), 60 Њ C (60 s) and 72 Њ C (60 s); third, 30 cycles at 94 Њ C (30 s), 56 Њ C (30 s) and 72 Њ C (30 s); and fourth, one cycle at 72 Њ C (5 min).
FISH analysis was performed by Dr. Art Brothman at the Molecular Cytogenetics Core Laboratory of the University of Utah. A P1 clone was used as the hybridization probe.
Sequence analysis. Sequencing was performed on plasmid subclones isolated from E. coli cultures by the alkaline lysis method. Sequencing of double stranded DNA templates was carried out using the dideoxy chain termination method (29) using the Sequenase 2.0 kit (U.S. Biochemicals, Cleveland, OH).
MaeII studies. The PCR products obtained using exon 9 primers (see above) were precipitated and the pellets resuspended in 20-40 l H 2 O. The samples were divided in two identical aliquots: one was treated with MaeII (Boehringer Mannheim, 2 U) for 3 h at 50 Њ C in a total volume of 25 l, following the specifications of the manufacturer. The other aliquot was not digested with MaeII. The digestion products then were subjected to electrophoresis on a 3% Metaphor™-agarose gel (FMC BioProducts, Rockland, ME), using a 100-bp DNA ladder (GIBCO-BRL, Gaithersburg, MD) as molecular weight standard.
Site-directed mutagenesis. PAF acetylhydrolase was expressed in E. coli , as described (16) . The construct for bacterial expression begins with Ile 42 inserted with the trp promoter and a translational start codon into the multiple cloning site of pUC19 (16) . The construct harboring the appropriate mutation was prepared by sequential PCR, as follows. Two sets of primers were synthesized. The first set consisted of the following primers:
The second set of primers was:
The initial set of reactions (100 l) contained DNA (10 ng of the above construct), 10 pmol of each oligonucleotide primer, 200 M each of dCTP, dTTP, dGTP, and dATP, 1.5 mM MgCl 2 , 10 mM Tris (pH 8.3 at 20 Њ C), 50 mM KCl, and 4 U of Taq polymerase (Boehringer Mannheim). Amplifications were performed as follows: first: one cycle at 94 Њ C for 5 min; second: 25 cycles at 94 Њ C (45 s), 50 Њ C (2 min) and 72 Њ C (2 min); third: one cycle at 72 Њ C (10 min). The products were analyzed by electrophoresis on a 1% SeaPlaque ® GTG ® Agarose (FMC BioProducts) and had the predicted sizes (733 and 509 bp for the first and second sets of primers, respectively). The next step consisted of amplification using both products obtained above, as templates (1-10 ng each) and sense primer I plus antisense primer II. The rest of the conditions were as described above. A 1230-bp product was obtained, purified as above and digested with XbaI and KpnI. This DNA was inserted into pUC 19 that had been modified for expression in bacteria, as described (16) . Sequence analysis revealed that the mutant had the desired G → T substitution at position 994. Genotype determination. Genotypes were determined by three independent amplifications. Genomic DNA (100 ng) was used as template in PCR reactions (15 l) containing 1.5 pmol of each oligonucleotide primer, 200 M each of dCTP, dTTP, dGTP, and dATP, 1.5 mM MgCl 2 , 10 mM Tris (pH 8.3 at 20 Њ C), 50 mM KCl, and 0.6 U of Taq polymerase (Boehringer Mannheim). The sense primer (Sense primer A) was the same for all reactions, and three antisense primers (B, C, and D) were synthesized for this study:
Amplifications were performed as follows: first, one cycle at 94 Њ C for 5 min; second, 5 cycles at 94ЊC (60 s), 56ЊC (60 s) and 72ЊC (60 s); third, 25 cycles at 94ЊC (30 s), 52ЊC (30 s) and 72ЊC (30 s); and fourth, one cycle at 72ЊC (5 min). The sizes of the products formed were: 160 bp when primers A and B were used, and 108 bp otherwise. The products were analyzed by electrophoresis on a 3% Metaphor ® -Agarose (FMC BioProducts).
Activity assays. PAF acetylhydrolase activity was determined as described (30) .
Results

Structure and organization of the PAF acetylhydrolase gene.
We first determined the organization of the PAF acetylhydro-lase gene by isolating three human genomic clones containing PAF acetylhydrolase sequences in bacteriophage P1 and vectors (Fig. 1 A) . We determined the restriction map of the insert sequences for several restriction enzymes (e. g., BglII, SacI, XbaI, EcoRI, BamHI, and HindIII) and subcloned restriction fragments corresponding to cDNA sequences. We then designed sense and antisense cDNA primers, to obtain sequence information of exonic and flanking regions.
The PAF acetylhydrolase gene is organized in 12 exons spanning at least 45 kb of DNA sequence. The first exon encodes 127 nt of 5Ј-untranslated sequence (Table I) . Exon 2 encodes 34 additional nt of 5Ј-untranslated sequence, coding sequence for the putative signal peptide (17 amino acid residues), and the first 19 amino acid residues of the mature protein (16) . Exons 3 through 12 contain the remaining coding sequence, beginning within the codon for the 20th amino acid of the mature protein and ending within the translational stop codon. The average exon size was 129 bp and the splice junctions agree favorably with consensus splice sites for mammalian genes (26) .
Chromosomal localization of the PAF acetylhydrolase gene. To determine the chromosomal location of the human plasma PAF acetylhydrolase gene, we used a panel of human/ rodent DNA hybrids from the NIGMS (somatic cell mapping panel No. 2) and primers localized in exon 6 (sense) and intron 7 (antisense). Products ‫ف(‬ 900 bp) were obtained from human genomic DNA, but not from mouse or hamster DNAs (Fig. 2  A, lanes A-C) , as expected. In addition, products were obtained from DNA templates harboring human chromosomes 1 and 6 ( Fig. 2 A, lanes 1 and 6) . To precisely establish the location of the PAF acetylhydrolase gene, we performed FISH analysis using a P1 clone obtained previously (Fig. 1 A) . Positive hybridization signals were observed at chromosome 6p12-21.1 on both chromosomes (Fig. 2 B) . The band assignment for FISH signals was determined by sequential FISH after G-banding. No signals were detected on chromosome 1, suggesting that the PCR products obtained using the rodent/human hybrid panel were nonspecific.
Identification of a point mutation in a PAF acetylhydrolase deficient subject. We analyzed DNA from an affected member of a Japanese family with inherited plasma PAF acetylhydrolase deficiency, as determined by the biochemical assay. DNA from a subject with normal enzymatic activity was tested simultaneously. We amplified genomic DNA from either deficient or normal subjects using primers designed from intronic sequences to the 5Ј and 3Ј of each coding exon (see Methods). These reactions yielded PCR products for each individual coding exon (not shown). In addition, the size of individual PCR products obtained from normal and deficient subjects was the same as determined by agarose gel electrophoresis (data not shown). These results ruled out the possibility that translocations, insertions or deletions accounted for PAF acetylhydrolase deficiency in this family, since these would have resulted in either no amplification, an increase or decrease in the size of the product, respectively. Thus, we considered the possibility that a point mutation was responsible for PAF acetylhydrolase deficiency. We used single stranded conformational polymorphism (SSCP), precise size determination on sequencing gels, and sequence analyses to detect alterations in the conformation and/or small size variations of exons obtained from deficient subjects. These studies resulted in the identification of polymorphisms that did not account for the observed defi- ciency in enzymatic activity because they occurred in non-coding regions of the gene (not shown).
Our next approach consisted in sequencing multiple clones of amplified exons derived from normal and deficient subjects. These studies revealed a single point mutation, a G→T transversion, at position 994 in the ninth exon, which contains the active site (16, 17) . This nucleotide change results in a nonconservative Val→Phe substitution at residue 279 of the mature PAF acetylhydrolase (Fig. 1 A) . Val 279 is conserved in plasma PAF acetylhydrolases from different species (human, mouse, dog, cow, and chicken; Fig. 1 B and reference 17 ) which suggests that it may be essential. In addition, PAF acetylhydrolase contains a Ser-Asp-His catalytic triad at the active site (17) and Val 279 lies between the active site ser and asp residues in a region that likely is critical for proper folding of the enzyme. These results suggested that the transition of Val 279 to Phe could account for the lack of enzymatic activity in this family.
Cosegregation of PAF acetylhydrolase activity and the point mutation. The G→T transversion generates a new restriction site for MaeII (Fig. 3 A) and we used this to test whether the enzymatic deficiency and the G→T mutation cosegregate in four Japanese families available for testing (Fig. 3 B) . The size of exon 9 amplified from subjects with normal PAF acetylhydrolase levels was not modified by MaeII digestion. However, DNA amplified from completely deficient subjects always gave two fragments (82 and 95 bp in length) when incubated with MaeII. Further, DNA from subjects characterized as heterozygous on the basis of a 50% decrease in plasma PAF acetylhydrolase activity had three fragments (82, 95, and 177 bp) after MaeII digestion indicating one normal and one mutant allele. Thus, the results from these small families were consistent with the interpretation that the Val 279 →Phe mutation accounts for PAF acetylhydrolase deficiency.
A single mutation accounts for PAF acetylhydrolase deficiency in all subjects tested. To expand this analysis of the significance of the Val 279 →Phe mutation, we tested an additional 41 Japanese subjects deficient in PAF acetylhydrolase activity. They were identified by enzymatic assay using plasma obtained from a random population of individuals participating in an annual screening examination. Exon 9 was amplified from genomic DNA of each subject, and the products were digested with MaeII and analyzed by electrophoresis (not shown). In all cases, the initial product (177 bp) was completely digested to 82 and 95 bp fragments by MaeII. Thus, all of the randomly selected deficient subjects had the suspected mutation. In contrast, this pattern was never observed in 84 individuals from the same population who had detectable enzymatic activity. These results indicate that the deficiency in PAF acetylhydrolase activity and the Val we expressed the normal and mutant cDNAs in E. coli (Fig. 4) . As shown by immunoreactivity, PAF acetylhydrolase protein was expressed to the same level by bacteria transformed with the normal and mutant constructs. However, the normal construct yielded a protein with enzymatic activity while the 5, and 6, respectively) . For illustrative purposes we show the results obtained from one subject of each category, but this test was applied to all family members from whom DNA samples were available. B shows four Japanese pedigrees with PAF acetylhydrolase deficiency. Individuals having no detectable plasma PAF acetylhydrolase activity are represented by black circles (females) and black squares (males). Unaffected individuals are represented by open circles (females) and open squares (males). Family members who have intermediate levels of activity are represented by shaded circles (females) and shaded squares (males). Individuals for whom no phenotypic data were available are identified by a question mark (?). Above each symbol, individual alleles are represented by a "ϩ" sign (normal exon 9) and/or a "Ϫ" sign (indicates G → T missense mutation in exon 9). Parentheses indicate that the genotype was predicted based on genetic and biochemical information from family members. PAF acetylhydrolase deficiency cosegregates with the mutation and individuals heterozygous for the mutation have lower activity levels than unaffected subjects. Informed consent was obtained from each family member before inclusion in the study. activity of PAF acetylhydrolase and accounts for the deficiency in Japanese subjects. To examine if the mutant protein was expressed in vivo, albeit in inactive form, we subjected plasma from deficient subjects to electrophoresis and Western blotting. We detected no immunoreactive protein in plasma from deficient subjects in contrast to normal plasma which expressed detectable levels of enzyme (Fig. 4, lower panel) . Thus, both plasma PAF acetylhydrolase activity and protein are lacking in these individuals.
Frequency of the G→T transversion in the Japanese and North American populations. Finally, we examined the allelic frequency of this mutation in the Japanese population. For this experiment we developed a rapid PCR assay that gives discrete products from the normal and mutant alleles and in control experiments showed that it accurately reflects the G→T transversion at position 994. This assay was developed to reduce the cost and to simplify the screening process. We used DNA isolated from 127 randomly selected Japanese subjects in specific PCR amplifications using three sets of primers (Fig.  5 A) . We also measured their plasma PAF acetylhydrolase activity (Fig. 5 B) . The mutant allele was present in 27% of the Japanese population as heterozygotes and 4% as homozygotes. This corresponded perfectly with enzyme activity levels (Fig. 5 B) . In contrast, no heterozygous or homozygous deficient subjects were identified in a random North American population (n ϭ 108, not shown). Both Miwa et al. (24) and we found a 4% prevalence of homozygous deficiency in Japan and our result of a 27% prevalence of heterozygosity agrees with the allele frequency predicted if the population is in HardyWeinberg equilibrium. We found that heterozygosity is established more conclusively by DNA analysis since enzymatic activity determinations revealed overlap between normal and heterozygous subjects (Fig. 5 B) . This was expected since we and others have shown that the levels of activity are regulated by environmental factors (4, 21, 31) .
Discussion
Human plasma PAF acetylhydrolase has potentially crucial physiological and pathological roles because it abolishes the diverse effects of PAF and oxidized phospholipids, which include inflammation and thrombosis. Decreased degradation of these biologically active molecules should result in pathological responses, and acquired PAF acetylhydrolase deficiency has been described in patients with systemic lupus erythematosus (21) and septic shock (32) .
The prevalence of asthma and allergic diseases has been reported to be low in Asian populations compared with the United Kingdom and Australia (33, 34) while other studies support the notion that the incidence of asthma is higher in Asian ethnic groups than in the White population (35) . This contradictory results are likely due to the lack of uniformity in the methodology used to define asthma and the complicated, multifactorial nature of the disease which make it difficult to compare prevalence data between studies (36). Leung and Ho (36) recently reported that family history is the strongest predicting factor for asthma and allergic symptoms in three Asian populations, conferring a 3-80-fold increase in risk to family members, which is significantly higher than the 2-3-fold increase found for Western Countries (37, 38) . These studies suggest that common genetic factors interact in a complex manner to initiate clinical asthma and allergy. Miwa et al. (24) showed that Japanese children with no detectable plasma PAF acetylhydrolase activity have a high prevalence of severe asthma. The natural history of individuals with PAF acetylhydrolase deficiency is not known since a cohort has not been followed prospectively nor are cross-sectional studies available. We predict that these individuals will have increased severity and incidence of inflammatory and allergic disorders. We propose that the function of plasma PAF acetylhydrolase is analogous to that of other protective plasma proteins such as protein C, which is a protease that suppresses coagulation, and ␣-1 antitrypsin, which inhibits the activity of proteases. Importantly, heterozygous subjects deficient in protein C show an increased risk of thrombosis when studied as part of a pedigree, but the modest increased risk is not apparent in populationbased studies (39, 40) . Similarly, patients deficient in ␣-1 antitrypsin often are modestly affected unless they smoke cigarettes, which leads to severe emphysema (41) . By analogy, patients Figure 4 . Expression of normal and mutant PAF acetylhydrolase gene: the G → T transition results in the production of inactive enzyme that can be detected by immunoblotting. Bacteria transformed with the PAF acetylhydrolase construct, the mutant construct and with vector alone were grown for 16 h at 37ЊC, harvested, lysed by sonication, and tested for PAF acetylhydrolase activity (30) . Additional aliquots (50 g for lanes 1, 4, and 7; 75 g for lanes 2, 5, and 8; and 100 g for lanes 3, 6, and 9) were subjected to electrophoresis on 10% acrylamide gels, as described (26) . The separated proteins were transferred to a PVDF membrane which was then probed with a rabbit polyclonal antibody against recombinant PAF acetylhydrolase. The blots were developed using alkaline phosphatase-labeled goat anti-rabbit IgG. The bottom panel is Western blot in which normal plasma and PAF acetylhydrolase deficient plasma were subjected to electrophoresis and transferred to a PVDF membrane, as above. The blots were developed using horesradish peroxidase-labeled goat antirabbit IgG and an enhanced chemiluminescence detection method.
with PAF acetylhydrolase deficiency may be relatively normal unless they develop inflammatory conditions mediated by PAF which would accumulate to high levels and initiate severe inflammation. The high frequency of the mutant allele is intriguing and may reflect a selective advantage in heterozygotes, although this is likely to be true only if it is a relatively ancient mutation.
We report here that the human PAF acetylhydrolase gene is located in chromosome 6p12.p21.1. Other genes have been localized to this region as well. A severe form of polycystic kidney disease maps to chromosome 6p21.1p12 (42) . In addition, juvenile myoclonic epilepsy has been recently shown to map to chromosome 6p21.2-p11 (43) and there is evidence that chromosome 6p carries a locus that predisposes to schizophrenia (44) . These findings are interesting as mRNA for plasma PAF acetylhydrolase has been detected in certain regions of the brain (16) and intracellular PAF acetylhydrolase activities have been purified and cloned from bovine brain (12, 13, (18) (19) (20) . This suggests that PAF and/or related lipids may have important neural signaling functions (45, 46) and that PAF acetylhydrolase activity may serve to modulate the actions of PAF and related lipids in the brain. The balance between PAF production and degradation may be an important factor in brain homeostasis and alterations in this balance may lead to human disease. Figure 5 . Frequency of missense mutation in the Japanese population. A shows the method used to establish heterozygosity in a population of randomly selected Japanese subjects. When both alleles are normal, products on the top (corresponding to the entire exon 9) and middle (corresponding to a partial exon 9 product containing the normal sequence) lanes should be produced, as in lane 13.
A homozygous deficient sample (lane 11) yields products in the top and bottom lanes (this latter one corresponds to a partial PCR product containing the mutation). A heterozygous sample should amplify using all three sets of primers, as in lane 12. Lane 14 is a control using water as template. The upper band is a control for amplification and has no discriminatory power. 10 samples are shown for illustrative purposes, but a population of 84 samples was screened using this assay. Samples shown on lanes 4, 6, and 10 were judged heterozygous; samples shown on lanes 1-3, 5, and 7-9 were judged normal. B shows the distribution of PAF acetylhydrolase activity in the population described above (composed of 84 samples with detectable levels of plasma PAF acetylhydrolase activity; completely deficient subjects were excluded from this study). A biphasic curve can be observed, with two maxima at ‫ف‬ 35 nmol/ml per min (average value for heterozygotes) and 70 nmol/ml per min (average value for normals).
